Representatives of US pharmacist and drug store groups had the floor for an hour recently at the Food and Drug Administration to make recommendations they’ve also made in comments submitted to the agency about making more drugs available OTC.
The groups’ representatives, in a meeting with FDA officials on 15 November, reiterated their general argument about the agency’s “additional
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?